Theracryf PLC Sustainability Reports
TheraCryf plc is a clinical-stage drug development company developing a new generation of innovative therapeutics. Its core operational focus spans the fields of oncology and neuropsychiatric behavioral brain disorders.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 213800NO3E6TSTQO8K20
FIGI: BBG007NTPDK7
3 reports from 2023 to 2025